恶性瘤的抗凝药:患者同时出血和凝血
Sargam Kapoor1, Andrew M Peseski1, Thomas L Ortel1,2
1Division of Hematology, Department of Medicine, Duke University, Durham, NC.
Hematology. American Society of Hematology. Education Program
|December 5, 2025
概括
需要抗凝血治疗的癌症患者面临来自瘤因素和治疗的高出血风险. 本综述详细介绍了这些风险和癌症相关血栓形成的安全抗凝药的策略.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有活跃恶性瘤的患者通常需要针对癌症相关血栓症,心房动或机械心脏门等疾病服用抗凝药.
- 与癌症相关的血栓形成显著增加了发病率和死亡率,在积极的癌症治疗期间需要长期抗凝药.
- 这一患者群面临着由于瘤特征,侵入性手术和诸如血小板狭窄等癌症疗法而增加的出血风险.
研究的目的:
- 概述癌症和血栓症患者出血的多因素风险因素.
- 在这个高风险人群中描述安全抗凝血的管理策略.
- 在需要抗凝药的癌症患者中,尽量减少血栓并发症和出血事件.
主要方法:
- 这是一个复习文章.
- 它综合了有关癌症患者在抗凝药上出血的风险因素的信息.
- 它讨论了安全抗凝固的管理策略.
主要成果:
- 多种因素导致出血风险升高,包括癌症部位 (例如脑瘤),侵入性手术和血栓塞缩症.
- 个体患者的因素,如药物和出血障碍,进一步增加出血风险.
- 有效的管理策略对于平衡抗凝血需求与出血问题至关重要.
结论:
- 在患有血栓形成的癌症患者中管理抗凝血需要仔细考虑许多相互作用的危险因素.
- 策略应专注于尽量减少出血,同时预防血栓事件.
- 对癌症患者优化抗凝血方案的进一步研究是有必要的.
相关概念视频
Venous Thrombosis III: Interprofessional Care
265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
Venous Thrombosis IV: Nursing Management
185
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
185
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Esophageal Varices-II: Clinical Features and Management
343
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
343

